Reliable HPLC method for therapeutic drug monitoring of frequently prescribed tricyclic and nontricyclic antidepressants
- 15 August 2007
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 44 (4) , 955-962
- https://doi.org/10.1016/j.jpba.2007.04.005
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority studyCurrent Medical Research and Opinion, 2007
- Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trialEuropean Psychiatry, 2006
- Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography–electrospray ionization mass spectrometry (HPLC–MS/ESI)Journal of Chromatography B, 2005
- A RANDOMIZED CONTROLLED TRIAL OF DULOXETINE ALONE, PELVIC FLOOR MUSCLE TRAINING ALONE, COMBINED TREATMENT AND NO ACTIVE TREATMENT IN WOMEN WITH STRESS URINARY INCONTINENCEJournal of Urology, 2005
- The Effect of Duloxetine on Painful Physical Symptoms in Depressed PatientsThe Journal of Clinical Psychiatry, 2004
- Therapeutic Drug Monitoring of AntidepressantsClinical Pharmacokinetics, 1999
- Duloxetine (LY 248686): an inhibitor of serotonin and noradrenaline uptake and an antidepressant drug candidateExpert Opinion on Investigational Drugs, 1998
- MirtazapineThe Journal of Clinical Psychiatry, 1998
- Metabolism of the Newer AntidepressantsClinical Pharmacokinetics, 1998
- Risk-Benefit Assessment of Newer Versus Older Monoamine Oxidase (MAO) InhibitorsDrug Safety, 1994